AIM is known as the world’s most successful growth market and it has been focused on delivering funding to companies looking to fund their development and pursue their growth ambitions since well before the 2015 changes to EIS and VCT, the Brexit vote, the Patient Capital Review and the 2017 Autumn budget. Marry this with a clear alignment with the Government’s growth-focused agenda for SMEs and scale-up and a strong performance in terms of returns and volatility in comparison to the main markets and you have a compelling case to take a more in-depth look at the sector. We know…

This content is for Free, Individual and Company members only.
Log In Register